Genestra DHA/EPA Vegan 60 capsules
Genestra DHA/EPA Vegan- 60 capsules
• High DHA essential fatty acid • Yields 360 mg DHA (Docosahexaenoic Acid) and 200 mg EPA (Eicosapentaenoic Acid). • Helps support cognitive health and/or brain function1 (100-3,000 mg EPA + DHA including at least 100 mg DHA, per day). • Helps support the development of the brain, eyes and nerves in children up to 12 years of age 2 (150-2,000 mg EPA + DHA including at least 150 mg DHA, per day). • Alternative to fish oil • Algal Oil (from Schizochytrium sp.) provides vegetable-derived option for vegans, vegetarians and those with sensitivities to fish oil. • Unique 2-piece hard vegetarian capsule technology • Unique capsule format minimizes sensitivity to heat and humidity while reducing oxidation potential. Limits odour and aftertaste.
Additional product info: DHA/EPA Vegan contains vegetable-derived DHA and EPA extracted from micro-algae (Algal Oil from Schizochytrium sp). It utilizes a unique encapsulating process: 2-piece hard shell which minimizes oxidation, limits odour and improves overall patient compliance. The manufacturing processes utilize nitrogen to purge the empty capsule – furthering oil preservation and reducing the risk of active migration.
Scientific Rationale Dietary sources of omega-3 (n-3) fatty acids (FA) are limited. The shorter chain (n-3) FA a-linolenic acid (ALA) is found in many plants, but the longer chain EPA and DHA are produced almost exclusively by cold water algae, which are in turn ingested by fish. Although humans cannot synthesize the (n-3) double bond, we do have the elongase and desaturase enzymes needed to convert ALA to EPA and DHA. However, this conversion is an inefficient process. The conversion of ALA to EPA may be further reduced as a result of large amounts of (n-6) FA in the diet, which compete for the same enzymes. Consequently, experts currently recommend the consumption of preformed EPA and DHA, rather than ALA, to meet dietary goals for (n-3) FA.3 EPA and DHA are crucial to cognitive health and/or brain function. DHA supplementation of breastfeeding mothers (approximately 200 mg algal DHA/day for 4 months after delivery) results in higher child plasma phospholipid DHA contents during supplementation and a higher Bayley Psychomotor Development Index at 30 months of age but results in no other advantages either at or before this age.4
References: 1. NHPD. Monograph on Fish Oil. March 2009. 2. NHPD. Monograph on Fish Oil. March 2009. 3. Neff LM, Culiner J, Cunningham-Rundles S, Seidman C, Meehan D, Maturi J, Wittkowski KM, Levine B, Breslow JL. Algal docosahexaenoic acid affects plasma lipoprotein particle size distribution in overweight and obese adults. J Nutr. 2011 Feb;141(2):207-13. 4. Jensen CL, Voigt RG, Prager TC, Zou YL, Fraley JK, Rozelle JC, Turcich MR, Llorente AM, Anderson RE, Heird WC. Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants. Am J Clin Nutr. 2005 Jul;82(1):125-32.
Other ingredients: Hypromellose, sunflower oil, sunflower lecithin, rosemary extract, natural mixed tocopherols, ascorbyl palmitate, silica